Mass. General Hospital-Harvard

Boston, Massachusetts 02114

0 studies enrolling now · 1 studies all time

What they study most

AML, Adult Recurrent, MDS

Studies at this site

• A Phase 1 Study With LYT-200 in Patients With Relapsed/Refractory Acute Myeloid Leukemia (AML), or With Relapsed/Refractory, High-risk Myelodysplastic Syndrome (MDS) — Completed